Searched for
PHARMACEUTICALS SECTOR
Symbiotec Pharmalab IPO Day 2: GMP signals 34% upside — Should you subscribe?Symbiotec Pharmalab's IPO saw robust investor demand, with the issue subscribed 1.85 times. The company aims to raise Rs 1,757 crore throug...- Indian companies step up acquisitions for AI, technology and talent: CrisilThe ratings agency said mergers and acquisitions are evolving from an occasional growth option into a core strategic tool for companies see...
- Convening India's brightest minds: The Bharat Life Sciences Award’s Innovation Summit to spotlight life sciencesIndia sets its sights on becoming a frontrunner in innovation within the life sciences arena. The Bharat Life Sciences Award 2026 aims to h...
- August Energy, Energeia partner to create $100 million energy-efficiency platform in IndiaAugust Energy and Energeia launch a $100 million platform for Indian businesses. This initiative focuses on decarbonisation without upfront...
- Widening trade gap with Japan a concern, Ficci flagsIndia's trade deficit with Japan is a growing concern for local exporters. Indian companies face hurdles accessing the Japanese market due ...
- Food prices on the rise, domestic demand keeps economy strongIndia's economy shows resilience with improved domestic demand and strong economic activity. Food prices have seen a broad-based increase, ...
- Broad-base rise in food prices despite monsoon recovery, RBI's state of economy report showsIndia's economy shows resilience with improved domestic demand and strong activity. Food prices have seen a broad-based increase, impacting...
- Boost for Ladakh: High-level panel to plan national sea buckthorn research hubA high-level committee will examine establishing a National Sanjeevani Research Centre for Sea Buckthorn. This initiative aims to position ...
- Capital goods sector to stay soft in H1, recovery seen in H2FY27 on thermal orders: ReportIndia’s capital goods and power equipment sector may remain subdued in the first half of FY27 before recovering later, 360 ONE Capital said...
- Symbiotec Pharmalab’s Rs 1,757 crore IPO opens with GMP hinting at 41% upside. Should you bid?Symbiotec Pharmalab IPO GMP: Symbiotec Pharmalab’s Rs 1,757 crore IPO opened August 24, with a Rs 938–988 price band and 41% grey-market pr...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Indian pharma has little reason to fear TrumpUS tariff threats on Indian generic drugs face significant obstacles. These duties could increase American healthcare costs and potentially...
- Rs 3,300 crore IPO week: Symbiotec, Skyways Air to lead 10-offer rush for investorsIndia's IPO market is set for a busy week, with 10 companies, including Symbiotec Pharmalab, Skyways Air Services, Hy-Tech Engineers and Lu...
- India gets nearly Rs 5,000 crore FDI after easing rules for Chinese-linked firmsNew foreign investment rules are yielding positive results for India's economy. Twenty-nine investment proposals totaling over Rs 4,895 cro...
- Capitalmind Flexi Cap Fund exits Vedanta and 10 others; adds 9 stocksDeepak Shenoy-backed Capitalmind Flexi Cap Fund exited 11 stocks, including Vedanta and Vedanta Oil and Gas, and added nine stocks, includi...
- Pharma giant Cipla completes merger with wholly-owned subsidiary Inzpera Health SciencesPharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficie...
- Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...
- Rupee, price tailwinds for Indian exporters may fade in H2FY27: NuvamaIndian exporters may see revenue tailwinds from rupee depreciation fade soon. Elevated prices and currency depreciation supported export gr...
- NFO Alert: Invesco Mutual Fund announces launch of pharma and healthcare fundInvesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...
- Need one or two Indian pharma firms to be among global top 5: PM ModiPrime Minister Modi urged Indian pharmaceutical companies to reach global top five. The Indian pharma industry ranks third globally by volu...
Load More
